Oakley-Girvan I - Search Results

1

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.

Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Werness BA, et al. Int J Gynecol Pathol. 2004 Jan;23(1):29-34. doi: 10.1097/01.pgp.0000101083.35393.cd. Int J Gynecol Pathol. 2004. PMID: 14668547

2

Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.

Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA. Ramus SJ, et al. Hum Mutat. 2007 Dec;28(12):1207-15. doi: 10.1002/humu.20599. Hum Mutat. 2007. PMID: 17688236

3

Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry.

Jishi MF, Itnyre JH, Oakley-Girvan IA, Piver MS, Whittemore AS. Jishi MF, et al. Cancer. 1995 Oct 15;76(8):1416-21. doi: 10.1002/1097-0142(19951015)76:8<1416::aid-cncr2820760818>3.0.co;2-d. Cancer. 1995. PMID: 8620417

4

Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients.

Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Oakley-Girvan I, et al. Am J Public Health. 2003 Oct;93(10):1753-9. doi: 10.2105/ajph.93.10.1753. Am J Public Health. 2003. PMID: 14534233 Free PMC article.

5

Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada.

Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Gong G, et al. Cancer Causes Control. 2002 Jun;13(5):471-82. doi: 10.1023/a:1015755219674. Cancer Causes Control. 2002. PMID: 12146852

6

Data-adaptive multi-locus association testing in subjects with arbitrary genealogical relationships.

Gong G, Wang W, Hsieh CL, Van Den Berg DJ, Haiman C, Oakley-Girvan I, Whittemore AS. Gong G, et al. Stat Appl Genet Mol Biol. 2019 Apr 8;18(3):/j/sagmb.2019.18.issue-3/sagmb-2018-0030/sagmb-2018-0030.xml. doi: 10.1515/sagmb-2018-0030. Stat Appl Genet Mol Biol. 2019. PMID: 30956231 Free PMC article.

7

Prediagnostic C-peptide and risk of prostate cancer.

Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Borugian MJ, et al. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2164-5. doi: 10.1158/1055-9965.EPI-07-0495. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17932367 No abstract available.

8

Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.

Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS Jr, Whittemore AS. Oakley-Girvan I, et al. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1325-30. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298953

9

Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study.

Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Borugian MJ, et al. Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):252-4. doi: 10.1158/1055-9965.EPI-07-2694. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18199733 No abstract available.

10

Geographic variation in Medicare treatment costs and outcomes for advanced head and neck cancer.

Divi V, Tao L, Whittemore A, Oakley-Girvan I. Divi V, et al. Oral Oncol. 2016 Oct;61:83-8. doi: 10.1016/j.oraloncology.2016.08.018. Epub 2016 Sep 6. Oral Oncol. 2016. PMID: 27688109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters